MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 7 (2010), Issue 4 (April)

1. A case of community-onset meningitis caused by hospital methicillin-resistant Staphylococcus aureus successfully treated with linezolid and rifampicin.
   Med Princ Pract, 19(3): 235-9. [Abstract] [Full-text]
2. Bacterial infections in horses: a retrospective study at the University Equine Clinic of Bern.
   Schweiz Arch Tierheilkd, 152(4): 176-82. [Abstract] [Full-text]
3. Community-associated methicillin-resistant Staphylococcus aureus infections.
   Br Med Bull. [Abstract] [Full-text]
4. Current diagnostic tools for methicillin-resistant Staphylococcus aureus infections.
   Mol Diagn Ther, 14(2): 73-80. [Abstract] [Full-text]
5. Molecular characteristics of the Taiwanese multiple drug-resistant ST59 clone of Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from pediatric cellulitis.
   J Infect Chemother, 16(2): 144-9. [Abstract] [Full-text]
6. Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy.
   J Infect Chemother, 16(2): 118-22. [Abstract] [Full-text]
7. Identification of the biosynthetic gene cluster for 3-methylarginine, a toxin produced by Pseudomonas syringae pv. syringae 22d/93.
   Appl Environ Microbiol, 76(8): 2500-8. [Abstract] [Full-text]
8. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
   Bioorg Med Chem, 18(7): 2611-20. [Abstract] [Full-text]
9. Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp.
   Foodborne Pathog Dis, 7(4): 435-41. [Abstract] [Full-text]
10. Discontinuation of contact precautions for patients no longer colonized with methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol, 31(5): 541-3. [Abstract] [Full-text]
11. Hospitalization earlier than 1 year prior to admission as an additional risk factor for methicillin-resistant Staphylococcus aureus colonization.
    Infect Control Hosp Epidemiol, 31(5): 538-40. [Abstract] [Full-text]
12. Prevalence of USA300 strain type of methicillin-resistant Staphylococcus aureus among patients with nasal colonization identified with active surveillance.
    Infect Control Hosp Epidemiol, 31(5): 469-75. [Abstract] [Full-text]
13. Evaluation of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for reporting methicillin-resistant Staphylococcus aureus infections at a hospital in Illinois.
    Infect Control Hosp Epidemiol, 31(5): 463-8. [Abstract] [Full-text]
14. Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.
    Infect Control Hosp Epidemiol, 31(5): 491-7. [Abstract] [Full-text]
15. Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.
    Diabetologia, 53(5): 914-23. [Abstract] [Full-text]
16. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
    J Antimicrob Chemother, 65(5): 1015-8. [Abstract] [Full-text]
17. Delayed diagnosis of tuberculous spondylitis masked by concomitant methicillin resistant Staphylococcus aureus infection.
    J Korean Neurosurg Soc, 47(3): 235-8. [Abstract] [Full-text]
18. Susceptibility of 169 USA300 methicillin-resistant Staphylococcus aureus isolates to two copper-based biocides, CuAL42 and CuWB50.
    J Antimicrob Chemother, 65(5): 939-41. [Abstract] [Full-text]
19. Microbiological study of pathogenic bacteria isolated from paediatric wound infections following the 2008 Wenchuan earthquake.
    Scand J Infect Dis, 42(5): 347-50. [Abstract] [Full-text]
20. Isolation rates of meticillin-resistant Staphylococcus aureus in dogs, cats and horses in Ireland.
    Vet Rec, 166(15): 451-5. [Abstract] [Full-text]
21. Vancomycin pharmacokinetics in patients with severe burn injuries.
    Burns, 36(4): 469-76. [Abstract] [Full-text]
22. Impact of hospital-wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit.
    J Hosp Infect, 75(1): 23-7. [Abstract] [Full-text]
23. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.
    Diagn Microbiol Infect Dis, 67(1): 1-8. [Abstract] [Full-text]
24. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus.
    PLoS Pathog, 6(4): e1000855. [Abstract] [Full-text]
25. Methicillin-resistant Staphylococcus aureus in surgical patients: identification of high-risk populations for the development of targeted screening programmes.
    Ann R Coll Surg Engl. [Abstract] [Full-text]
26. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures.
    Clin Microbiol Infect. [Abstract] [Full-text]
27. Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme.
    Appl Microbiol Biotechnol, 86(5): 1439-49. [Abstract] [Full-text]
28. In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.
    Eur J Clin Microbiol Infect Dis, 29(5): 503-7. [Abstract] [Full-text]
29. Prevalence and clonality of methicillin-resistant Staphylococcus aureus (MRSA) in the Atlantic Azores islands: predominance of SCCmec types IV, V and VI.
    Eur J Clin Microbiol Infect Dis, 29(5): 543-50. [Abstract] [Full-text]
30. Methicillin-resistant Staphylococcus aureus in TKA Treated With Revision and Direct Intraarticular Antibiotic Infusion.
    Clin Orthop Relat Res. [Abstract] [Full-text]
31. Nursing home-acquired pneumonia: a 10 year single-centre experience.
    Thorax, 65(4): 354-9. [Abstract] [Full-text]
32. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine.
    Clin Microbiol Infect, 16(5): 432-8. [Abstract] [Full-text]
33. Evaluating the usefulness of spa typing, in comparison with pulsed-field gel electrophoresis, for epidemiological typing of methicillin-resistant Staphylococcus aureus in a low-prevalence region in Sweden 2000-2004.
    Clin Microbiol Infect, 16(5): 456-62. [Abstract] [Full-text]
34. Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia.
    Clin Microbiol Infect, 16(5): 463-9. [Abstract] [Full-text]
35. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections.
    Clin Microbiol Infect, 16(5): 425-31. [Abstract] [Full-text]
36. Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility.
    J Am Acad Dermatol, 62(5): 804-11. [Abstract] [Full-text]
37. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Int J Antimicrob Agents, 35(6): 559-65. [Abstract] [Full-text]
38. Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981-2007.
    J Infect Dis, 201(10): 1589-97. [Abstract] [Full-text]
39. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
    Int J Antimicrob Agents, 35(6): 527-30. [Abstract] [Full-text]
40. Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
    Antimicrob Agents Chemother, 54(5): 2258-61. [Abstract] [Full-text]
41. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
    Antimicrob Agents Chemother, 54(5): 1955-64. [Abstract] [Full-text]
42. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain.
    Antimicrob Agents Chemother, 54(5): 2212-5. [Abstract] [Full-text]
43. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period.
    Antimicrob Agents Chemother, 54(5): 1842-7. [Abstract] [Full-text]
44. Antistaphylococcal activity of Zataria multiflora essential oil and its synergy with vancomycin.
    Phytomedicine, 17(7): 548-50. [Abstract] [Full-text]
45. Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
    Antimicrob Agents Chemother, 54(5): 2201-5. [Abstract] [Full-text]
46. Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents.
    Antimicrob Agents Chemother, 54(5): 2112-8. [Abstract] [Full-text]
47. Differentiation of clonal complex 59 community-associated methicillin-resistant Staphylococcus aureus in Western Australia.
    Antimicrob Agents Chemother, 54(5): 1914-21. [Abstract] [Full-text]
48. Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
    Antimicrob Agents Chemother, 54(5): 1670-7. [Abstract] [Full-text]
49. Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008.
    Antimicrob Agents Chemother, 54(5): 2265-8. [Abstract] [Full-text]
50. Significance of MRSA strains in community associated skin and soft tissue infections.
    Indian J Med Microbiol, 28(2): 152-4. [Abstract] [Full-text]
51. Characterisation of methicillin resistant S. aureus strains and risk factors for acquisition in a teaching hospital in northeast India.
    Indian J Med Microbiol, 28(2): 127-9. [Abstract] [Full-text]
52. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples.
    Indian J Med Microbiol, 28(2): 124-6. [Abstract] [Full-text]
53. Ceftaroline for complicated skin and skin-structure infections.
    Expert Opin Pharmacother, 11(7): 1197-206. [Abstract] [Full-text]
54. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ann Pharmacother, 44(5): 918-21. [Abstract] [Full-text]
55. An overview of livestock-associated MRSA in agriculture.
    J Agromedicine, 15(2): 101-4. [Abstract] [Full-text]
56. Planting the seed: the 2009 Midwest Rural Agricultural Safety and Health Forum (MRASH).
    J Agromedicine, 15(2): 87-9. [Abstract] [Full-text]
57. The prevalence of carriage of meticillin-resistant staphylococci by veterinary dermatology practice staff and their respective pets.
    Vet Dermatol. [Abstract] [Full-text]
58. Photodamage to Multidrug-resistant Gram-positive and Gram-negative Bacteria by 870 nm/930 nm Light Potentiates Erythromycin, Tetracycline and Ciprofloxacin.
    Photochem Photobiol. [Abstract] [Full-text]
59. Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis.
    Am J Health Syst Pharm, 67(9): 737-40. [Abstract] [Full-text]
60. Successful medical treatment of bioprosthetic pulmonary valve endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Pediatr Cardiol, 31(4): 553-5. [Abstract] [Full-text]
61. Decreased susceptibility to zinc chloride is associated with methicillin resistant Staphylococcus aureus CC398 in Danish swine.
    Vet Microbiol, 142(3): 455-7. [Abstract] [Full-text]
62. Heterogeneity among methicillin-resistant Staphylococcus aureus from Italian pig finishing holdings.
    Vet Microbiol, 142(3): 361-6. [Abstract] [Full-text]
63. Crossbyanols A-D, toxic brominated polyphenyl ethers from the Hawai'ian bloom-forming Cyanobacterium Leptolyngbya crossbyana.
    J Nat Prod, 73(4): 517-22. [Abstract] [Full-text]
64. Development of nanostructured silver vanadates decorated with silver nanoparticles as a novel antibacterial agent.
    Nanotechnology, 21(18): 185102. [Abstract] [Full-text]
65. Enduracidin analogues with altered halogenation patterns produced by genetically engineered strains of Streptomyces fungicidicus.
    J Nat Prod, 73(4): 583-9. [Abstract] [Full-text]
66. Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide production.
    Cell Host Microbe, 7(4): 277-89. [Abstract] [Full-text]
67. Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by Staphylococcus aureus.
    FEMS Microbiol Lett. [Abstract] [Full-text]
68. UK Renal Registry 12th Annual Report (December 2009): Chapter 12: Epidemiology of methicillin resistant Staphylococcus aureus bacteraemia amongst patients receiving dialysis for established renal failure in England in 2008: a joint report from the UK Renal Registry and the Health Protection Agency.
    Nephron Clin Pract, 115: c261-70. [Abstract] [Full-text]
69. Trimethoprim-sulfamethoxazole-induced hepatotoxicity in a pediatric patient.
    Pharmacotherapy, 30(5): 539. [Abstract] [Full-text]
70. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient.
    Ann Emerg Med, 55(5): 401-7. [Abstract] [Full-text]
71. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
    J Ocul Pharmacol Ther, 26(2): 193-8. [Abstract] [Full-text]
72. Scanning electron microscopy visualization of methicillin-resistant Staphylococcus aureus after contact with gatifloxacin with and without preservative.
    J Ocul Pharmacol Ther, 26(2): 133-6. [Abstract] [Full-text]
73. Time-kill assay results for a linalool-hinokitiol-based eyelid cleanser for lid hygiene.
    Cornea, 29(5): 559-63. [Abstract] [Full-text]
74. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation.
    PLoS One, 5(4): e10146. [Abstract] [Full-text]
75. The transmission of nosocomial pathogens in an intensive care unit: a space-time clustering and structural equation modelling approach.
    Epidemiol Infect, 138(6): 915-26. [Abstract] [Full-text]
76. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia.
    Am J Infect Control, 38(4): 315-8. [Abstract] [Full-text]
77. Control of methicillin-resistant Staphylococcus aureus in planktonic form and biofilms: a biocidal efficacy study of nonthermal dielectric-barrier discharge plasma.
    Am J Infect Control, 38(4): 293-301. [Abstract] [Full-text]
78. Survey of employee knowledge and attitudes before and after a multicenter Veterans' Administration quality improvement initiative to reduce nosocomial methicillin-resistant Staphylococcus aureus infections.
    Am J Infect Control, 38(4): 274-82. [Abstract] [Full-text]
79. Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological properties.
    J Antibiot (Tokyo), 63(4): 151-5. [Abstract] [Full-text]
80. Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. II: Structure elucidation.
    J Antibiot (Tokyo), 63(4): 157-63. [Abstract] [Full-text]
81. Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers.
    Am J Infect Control, 38(4): 324-8. [Abstract] [Full-text]
82. Comparative molecular analysis of meticillin-resistant Staphylococcus aureus isolates from children with atopic dermatitis and healthy subjects in Taiwan.
    Br J Dermatol, 162(5): 1110-6. [Abstract] [Full-text]
83. Contribution of two molecular assays as compared to selective culture for MRSA screening in a low MRSA prevalence population.
    Infection, 38(2): 98-101. [Abstract] [Full-text]
84. A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features.
    Infection, 38(2): 102-7. [Abstract] [Full-text]
85. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.
    Perit Dial Int, 30(3): 311-9. [Abstract] [Full-text]
86. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children.
    Pediatr Infect Dis J, 29(5): 410-4. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.